RYTM
Rhythm Pharmaceuticals Inc
Price:  
55.24 
USD
Volume:  
519,522.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RYTM WACC - Weighted Average Cost of Capital

The WACC of Rhythm Pharmaceuticals Inc (RYTM) is 8.6%.

The Cost of Equity of Rhythm Pharmaceuticals Inc (RYTM) is 8.75%.
The Cost of Debt of Rhythm Pharmaceuticals Inc (RYTM) is 5.00%.

Range Selected
Cost of equity 7.10% - 10.40% 8.75%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 7.0% - 10.3% 8.6%
WACC

RYTM WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.7 1
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.10% 10.40%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0.03 0.03
Cost of debt 5.00% 5.00%
After-tax WACC 7.0% 10.3%
Selected WACC 8.6%